Variability of antioxidant-related gene expression in the airway epithelium of cigarette smokers

American Journal of Respiratory Cell and Molecular Biology

Volumn 29, Issue 3 I, 2003, Pages 331-343

  Hackett, Neil R ^b   Heguy, Adriana ^b   Harvey, Ben Gary ^b   O'Connor, Timothy P ^b   Luettich, Karsta ^b   Flieder, Douglas B ^b   Kaplan, Rana ^b   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CATALASE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CHRONIC BRONCHITIS; CIGARETTE SMOKING; CLINICAL ARTICLE; DNA MICROARRAY; FEMALE; GENE CONTROL; GENE EXPRESSION; GENETIC VARIABILITY; GLUTATHIONE METABOLISM; HUMAN; MALE; OXIDATION REDUCTION REACTION; PENTOSE PHOSPHATE CYCLE; RESPIRATORY EPITHELIUM; UPREGULATION;

ADULT; ANTIOXIDANTS; CLUSTER ANALYSIS; COHORT STUDIES; DNA, COMPLEMENTARY; DOWN-REGULATION; EPITHELIUM; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDANTS; OXIDATION-REDUCTION; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RNA, COMPLEMENTARY; SMOKING; UP-REGULATION; VARIATION (GENETICS);

EID: 0042831342     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2002-0321OC     Document Type: Article

References (46)

1. American Thoracic Society. 1995. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit Care Med. 152:S77-S121.
2. Anthonisen, N. R., et al. 1994. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 272:1497-1505.
3. Sethi, J. M., and C. L. Rochester. 2000. Smoking and chronic obstructive pulmonary disease. Clin. Chest Med. 21:67-86.
4. Repine, J. E., A. Bast, and I. Lankhorst. 1997. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am. J. Respir. Crit. Care Med. 156:341-357.
5. Rahman, I., and W. MacNee. 1999. Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am. J. Physiol. 277:L1067-L1088.
6. Fletcher, C., R. Peto, and C. Tinker. 1976. The natural history of chronic bronchitis and emphysema: an eight-year study of early chronic obstructive lung disease in working men in London. Oxford University Press, London.
7. Silverman, E. K., et al. 1998. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am. J. Respir. Crit. Care Med. 157:1770-1778.
8. Sandford, A. J., and E. K. Silverman. 2002. Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction. Thorax 57:736-741.
9. Danel, C., S. C. Erzurum, N. G. McElvaney, and R. G. Crystal. 1996. Quantitative assessment of the epithelial and inflammatory cell populations in large airways of normals and individuals with cystic fibrosis. Am. J. Respir. Crit. Care Med. 153:362-368.
10. Russi, T. J., and R. G. Crystal. 1997. Bronchoalveolar lavage and airway brushing to investigate the human lung. In The Lung: Scientific Foundations. Lippencott-Raven, Inc., Philadelphia. 371-382.
11. Harvey, B. G., et al. 1999. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus. J. Clin. Invest. 104:1245-1255.
12. Willey, J. C., et al. 1997. Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers. Am. J. Respir. Cell Mol. Biol. 17:114-124.
13. Spivack, S. D., et al. 2001. CYP1B1 expression in human lung. Drug Metab. Dispos. 29:916-922.
14. Erzurum, S. C., et al. 1993. In vivo antioxidant gene expression in human airway epithelium of normal individuals exposed to 100% O2. J. Appl. Physiol. 75:1256-1262.
15. Yoo, J. H., S. C. Erzurum, J. G. Hay, P. Lemarchand, and R. G. Crystal. 1994. Vulnerability of the human airway epithelium to hyperoxia. Constitutive expression of the catalase gene in human bronchial epithelial cells despite oxidant stress. J. Clin. Invest 93:297-302.
16. Chou, C. F., C. L. Lai, Y. C. Chang, G. Duester, and S. J. Yin. 2002. Kinetic mechanism of human class IV alcohol dehydrogenase functioning as retinol dehydrogenase. J. Biol. Chem. 277:25209-25216.
17. Burczynski, M. E., G. R. Sridhar, N. T. Palackal, and T. M. Penning. 2001. The reactive oxygen species-and Michael acceptor-inducible human aldo-keto reductase AKR1C1 reduces the alpha,beta-unsaturated aldehyde 4-hydroxy-2-nonenal to 1,4-dihydroxy-2-nonene. J. Biol. Chem. 276:2890-2897.
18. Arner, E. S., and A. Holmgren. 2000. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267:6102-6109.
19. Pryor, W. A., and K. Stone. 1993. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann. N. Y. Acad. Sci. 686:12-27.
20. Deliconstantinos, G., V. Villiotou, and J. C. Stavrides. 1994. Scavenging effects of hemoglobin and related heme containing compounds on nitric oxide, reactive oxidants and carcinogenic volatile nitrosocompounds of cigarette smoke. A new method for protection against the dangerous cigarette constituents. Anticancer Res. 14:2717-2726.
21. Spencer, J. P., et al. 1995. DNA damage in human respiratory tract epithelial cells: damage by gas phase cigarette smoke apparently involves attack by reactive nitrogen species in addition to oxygen radicals. FEBS Lett. 375:179-182.
22. Reilly, M., N. Delanty, J. A. Lawson, and G. A. Fitz Gerald. 1996. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94:19-25.
23. Nakayama, T., M. Kodama, and C. Nagata. 1984. Generation of hydrogen peroxide and superoxide anion radical from cigarette smoke. Gann 75:95-98.
24. Morrow, J. D., et al. 1995. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N. Engl. J. Med. 32:1198-1203.
25. Altuntas, I., S. Dane, and K. Gumustekin. 2002. Effects of cigarette smoking on lipid peroxidation. J. Basic Clin. Physiol. Pharmacol. 13:69-72.
26. Ho, Y. S., et al. 2002. Lipid peroxidation and cell death mechanisms in pulmonary epithelial cells induced by peroxynitrite and nitric oxide. Arch. Toxicol. 76:484-493.
27. Rahman, I., D. Morrison, K. Donaldson, and W. MacNee. 1996. Systemic oxidative stress in asthma, COPD, and smokers. Am. J. Respir. Crit. Care Med. 154:1055-1060.
28. Rennard, S. I. 2002. Overview of causes of COPD: new understanding of pathogenesis and mechanisms can guide future therapy. Postgrad. Med. 111:28-38.
29. Wouters, E. F., E. C. Creutzberg, and A. M Schols. 2002. Systemic effects in COPD. Chest 121:127S-130S.
30. Linden, M., et al. 1993. Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis. Am. Rev. Respir. Dis. 148:1226-1232.
31. Asami, S., et al. 1997. Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung. Carcinogenesis 18:1763-1766.
32. van Zeeland, A. A., A. J. de Groot, J. Hall, and F. Donato. 1999. 8-Hydroxydeoxyguanosine in DNA from leukocytes of healthy adults: relationship with cigarette smoking, environmental tobacco smoke, alcohol and coffee consumption. Mutat. Res. 439:249-257.
33. MacNee, W. 2000. Oxidants/antioxidants and COPD. Chest 117:303S-317S.
34. Comhair, S. A., and S. C. Erzurum. 2002. Antioxidant responses to oxidant-mediated lung diseases. Am. J. Physiol. 283:L246-L255.
35. Luo, J. L., C. S. Huang, K. Babaoglu, and M. E. Anderson. 2000. Novel kinetics of mammalian glutathione synthetase: characterization of gamma-glutamyl substrate cooperative binding. Biochem. Biophys. Res. Commun. 275:577-581.
36. Rahman, I., et al. 2000. Localization of gamma-glutamylcysteine synthetase messenger RNA expression in lungs of smokers and patients with chronic obstructive pulmonary disease. Free Radic. Biol. Med. 28:920-925.
37. Cantin, A. M., S. L. North, R. C. Hubbard, and R. G. Crystal. 1987. Normal alveolar epithelial lining fluid contains high levels of glutathione. J. Appl. Physiol. 63:152-157.
38. Gilks, C. B., K. Price, J. L. Wright, and A. Churg. 1998. Antioxidant gene expression in rat lung after exposure to cigarette smoke. Am. J. Pathol. 152:269-278.
39. Cho, H. Y., et al. 2002. Role of NRF2 in protection against hyperoxic lung injury in mice. Am. J. Respir. Cell Mol. Biol. 26:175-182.
40. Comhair, S. A., M. J. Thomassen, and S. C. Erzurum. 2000. Differential induction of extracellular glutathione peroxidase and nitric oxide synthase 2 in airways of healthy individuals exposed to 100% O2 or cigarette smoke. Am. J. Respir. Cell Mol. Biol. 23:350-354.
41. Kozar, R. A., et al. 2000. Antioxidant enzymes are induced during recovery from acute lung injury. Crit. Care Med. 28:2486-2491.
42. Crystal, R. G. 1989. The α1-antitrypsin gene and its deficiency states. Trends Genet. 5:411-417.
43. Mahadeva, R., and D. A. Lomas. 1998. Genetics and respiratory disease: 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema. Thorax 53:501-505.
44. Harrison, D. J., A. M. Cantlay, F. Rae, D. Lamb, and C. A. Smith. 1997. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer. Hum. Exp. Toxicol. 16:356-360.
45. Eisen, M. B., P. T. Spellman, P. O. Brown, and D. Botstein. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95:14863-14868.
46. Benjamini, Y., and Y, Hochberg. 1995. Controlling the false discovery rate: a practical and approach to multiple testing. J. R. Statist. Soc. B 57:289-300.